Yes, ammonia levels should be evaluated in a 3-month-old infant with severe growth faltering
Ammonia measurement is an essential investigation in infants presenting with severe growth faltering, particularly when accompanied by poor feeding, lethargy, vomiting, or developmental concerns, as these may represent late-onset presentations of inborn errors of metabolism such as urea cycle disorders or organic acidemias.
Why Ammonia Testing is Critical in This Context
Growth Faltering as a Metabolic Red Flag
Late-onset hyperammonemia in infants beyond the neonatal period can present with failure to thrive as a prominent feature 1. Unlike the acute neonatal presentations that occur within days of birth, partial or mild deficiencies in urea cycle enzymes may manifest more insidiously at 3 months with:
- Failure to thrive/growth faltering
- Irritability
- Poor feeding and vomiting
- Lethargy or decreased responsiveness
- Developmental delays
Diagnostic Thresholds and Normal Values
Hyperammonemia in term infants, children, and adolescents is defined as ≥50 µmol/l (85 µg/dl) 1. However, normal plasma ammonia concentrations in young infants can be higher than adult values, with proposed reference limits ≤82 μmol/L for newborns less than one week of age 2. At 3 months, values should be closer to the standard pediatric threshold.
High-Risk Metabolic Conditions
The primary differential diagnosis for hyperammonemia in infants includes 1:
- Urea cycle disorders (UCDs): Occur in ~1 in 35,000 births, with ornithine transcarbamylase (OTC) deficiency being most common (1 in 56,500 births)
- Organic acidemias: Including methylmalonic acidemia, propionic acidemia, and isovaleric acidemia (occur in ~1 in 21,000 births)
- Secondary causes: Liver disease, acute liver or kidney injury
Clinical Approach: When to Measure Ammonia
Specific Clinical Indicators in Growth Faltering
Measure plasma ammonia urgently if the 3-month-old with growth faltering exhibits any of:
- Poor feeding or feeding refusal (early sign)
- Lethargy or decreased responsiveness
- Vomiting (particularly recurrent or unexplained)
- Tachypnea or respiratory alkalosis
- Hypotonia
- Developmental regression or delays
- Seizures (late/severe sign)
Critical Timing Consideration
Plasma ammonia should be measured at the same time as a septic screen in deteriorating infants 3. Do not delay measurement waiting for other test results. Patients with metabolic disorders deteriorate over hours, and investigation cannot wait 4.
Interpretation and Action Thresholds
Ammonia Level-Based Management
- <50 µmol/L: Generally normal for this age
- 50-200 µmol/L: Abnormal; investigate for metabolic disorders
- >200 µmol/L: Usually caused by inherited metabolic diseases; requires urgent metabolic workup 3
- >500 µmol/L: Requires immediate dialysis consideration 3
- >800 µmol/L for >24 hours: Associated with irreversible neurological damage 3
Concurrent Investigations
When ammonia is elevated, immediately obtain:
- Plasma amino acids
- Urine organic acids
- Blood gas (look for respiratory alkalosis)
- Liver function tests
- Lactate
- Glucose
Morbidity and Mortality Implications
Ammonia levels >200 µmol/l (341 µg/dl) are associated with poor neurological outcomes 1. The duration of hyperammonemic coma prior to treatment is the most important prognostic factor 1. Early identification through appropriate screening in at-risk infants (including those with growth faltering) is critical for:
- Preventing cerebral edema and neurological impairment
- Enabling timely genetic diagnosis for family counseling
- Initiating life-saving treatment before irreversible brain damage occurs
Common Pitfalls to Avoid
Pre-analytical Errors
Plasma ammonia measurement has significant preanalytical challenges 5. To obtain reliable results:
- Use EDTA or heparinized tubes on ice
- Transport immediately to laboratory
- Process within 15 minutes
- Avoid hemolysis and prolonged tourniquet time
False Reassurance
Do not assume metabolic disease only presents in the neonatal period. Late-onset presentations at 3 months are well-documented, particularly in females with OTC deficiency who may have milder phenotypes 6.
Threshold for Testing
The threshold for accepting ammonia requests should be lower than current practice to prevent misdiagnoses 4. In an infant with unexplained severe growth faltering, the cost and risk of missing a treatable metabolic disorder far outweigh the cost of the test.